Protalix BioTherapeutics, Inc.

Ticker PLX

Exchange AMEX More
Industry Biotechnology More
Sector Healthcare More

201-500 Employees
Based in Karmiel, Israel

Protalix BioTherapeutics, Inc., a biopharmaceutical company, through Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in the United States.

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (264)

Protalix BioTherapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 264 reviews.

Protalix BioTherapeutics, Inc.

Most Recent Annual Report

MOST RECENT 2022 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Protalix BioTherapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.